Multiplex Assay Kit for Phospholipase A2, Calcium Independent (iPLA2) ,etc. by CBA (Cytometric Bead Array)

PLA2G6; CaI-PLA2; GVI; INAD1; PNPLA9; Ca2+ Independent PLA2; 85 kDa Calcium-Independent Phospholipase A2; Phospholipase A2,group VI(Cytosolic,Calcium-Independent)

Specificity

This assay has high sensitivity and excellent specificity for detection of Phospholipase A2, Calcium Independent (iPLA2) ,etc. by CBA (Cytometric Bead Array).
No significant cross-reactivity or interference between Phospholipase A2, Calcium Independent (iPLA2) ,etc. by CBA (Cytometric Bead Array) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Phospholipase A2, Calcium Independent (iPLA2) ,etc. by CBA (Cytometric Bead Array) and the recovery rates were calculated by comparing the measured value to the expected amount of Phospholipase A2, Calcium Independent (iPLA2) ,etc. by CBA (Cytometric Bead Array) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 98-105 101
EDTA plasma(n=5) 84-98 95
heparin plasma(n=5) 92-99 96

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Phospholipase A2, Calcium Independent (iPLA2) ,etc. by CBA (Cytometric Bead Array) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Phospholipase A2, Calcium Independent (iPLA2) ,etc. by CBA (Cytometric Bead Array) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Phospholipase A2, Calcium Independent (iPLA2) ,etc. by CBA (Cytometric Bead Array) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 84-101% 93-101% 85-93% 83-101%
EDTA plasma(n=5) 79-101% 92-101% 97-105% 91-101%
heparin plasma(n=5) 79-102% 98-105% 78-88% 96-104%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity

Assay procedure summary

1. Add 200μL analysis buffer solution to each well of the plate for pre-wetting;
2. Preparation of standards, reagents and samples before the experiment;
3. Add 100μL standard or sample to each well, add 10μL magnetic beads, and incubate 120 minutes protect from light at 25°C on shaker;
4. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60 minutes protect from light at 25°C on shaker;
5. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent B, and incubate 30 minutes protect from light at 25°C on shaker;
6. Wash plate once on magnetic frame;
7. Add 100μL sheath fluid, swirl for 10 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Oncotarget Anti-cancer effect of snake venom toxin through down regulation of AP-1 mediated PRDX6 expression PubMed: 26061816
Bulletin of Experimental Biology and Medicine Polyunsaturated Fatty Acids and Their Correlations with Parameters of Oxidative/Antioxidant Potential of the Blood and Lipoprotein-Associated Phospholipase A2 in … Pubmed: 30417304
American Journal of Physiology. LungCellular and Molecular Physiology Effect of cooling on lung secretory phospholipase A2 activity in vitro, ex vivo and in vivo Pubmed: 30604626
Psychiatry Research An investigation of calcium-independent phospholipase A2 (iPLA2) and cytosolic phospholipase A2 (cPLA2) in schizophrenia Doi: 10.1016/j.psychres.2019.01.095
Neurosurgery Is Admission Lipoprotein-Associated Phospholipase A2 a Novel Predictor of Vasospasm and Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage? Pubmed: 30850840
Journal of Medical Biochemistry CHANGES IN THE BLOOD FATTY-ACID PROFILE ASSOCIATED WITH OXIDATIVE-ANTIOXIDANT DISTURBANCES IN CORONARY ATHEROSCLEROSIS
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA411Hu01 Recombinant Phospholipase A2, Calcium Independent (iPLA2) Positive Control; Immunogen; SDS-PAGE; WB.
PAA411Hu01 Polyclonal Antibody to Phospholipase A2, Calcium Independent (iPLA2) WB; IHC
MAA411Hu22 Monoclonal Antibody to Phospholipase A2, Calcium Independent (iPLA2) WB; IHC; ICC; IP.
SEA411Hu ELISA Kit for Phospholipase A2, Calcium Independent (iPLA2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA411Hu Multiplex Assay Kit for Phospholipase A2, Calcium Independent (iPLA2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
CMA411Hu Multiplex Assay Kit for Phospholipase A2, Calcium Independent (iPLA2) ,etc. by CBA (Cytometric Bead Array) FLIA Kit for Antigen Detection.